Akorn Holding Company LLC
Case Number:
1:23-bk-10253
Court:
Nature of Suit:
Firms
- A. M. Saccullo Legal
- Archer & Greiner
- Ashby & Geddes
- Baker Botts
- Ballard Spahr
- Barnes & Thornburg
- Bielli & Klauder
- Buchalter APC
- Buchanan Ingersoll
- Chiesa Shahinian
- Chipman Brown
- Clark Hill
- Connolly Gallagher
- Cozen O'Connor
- Dickie McCamey
- Duane Morris
- Faegre Drinker
- Flaster Greenberg
- Foley Hoag
- Fox Rothschild
- Gibson Dunn
- Glenn Agre
- Greenberg Traurig
- Hackett Feinberg
- Jacob & Weingarten
- Kaplan & Gournis
- Kilpatrick Townsend
- Kirkland & Ellis
- Klehr Harrison
- K&L Gates
- Kramer Levin
- Landis Rath
- Latham & Watkins
- Law Office of James Tobia
- Law Office of Susan E. Kaufman
- Leech Tishman
- Lewis Brisbois
- Lowenstein Sandler
- Manier & Herod
- Margolis Edelstein
- McCarter & English
- McElroy Deutsch
- Morris James
- Morris Nichols
- Pachulski Stang
- Paul Hastings
- Porzio Bromberg
- Potter Anderson
- Powell Firm
- Proskauer Rose
- Richards Layton
- Saul Ewing
- Sequor Law
- Taft Stettinius
- Troutman Pepper
- Tucker Arensberg
- Weil Gotshal
- Whiteford Taylor
- Windels Marx
- Womble Bond
- Young Conaway
Companies
- Akorn Inc.
- Aurobindo Pharma Ltd.
- Cardinal Health Inc.
- Cencora Inc.
- Commonwealth Edison Co.
- Credit Suisse Group AG
- Ethypharm S.A.
- Evoqua Water Technologies LLC
- Fareva SA
- GSMS Inc.
- Hain Capital Group LLC
- Heritage Global Inc.
- Hikma Pharmaceuticals PLC
- Iron Mountain Inc.
- Leadiant Biosciences Inc.
- Loomis Sayles & Co. LP
- Managed Health Care Associates Inc.
- McKesson Corp.
- Oracle Corp.
- Particle Measuring Systems Inc.
- Prestige Consumer Healthcare Inc.
- Syneos Health Inc.
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific Inc.
- TR Capital Management LLC
Government Agencies
- New York State Department of Health
- Oregon Health Authority
- Texas Comptroller of Public Accounts
- U.S. Customs and Border Protection
Sectors & Industries:
-
August 23, 2024
Drug Cos. Akorn, Cardinal Settle $28M Ch. 7 Fight
Defunct drug manufacturer Akorn has told Delaware's bankruptcy court it reached an agreement resolving a roughly $28 million dispute regarding its prepetition sale of pharmaceuticals to distributor Cardinal Health, which promised to pay nearly $7 million to the debtor's Chapter 7 estate.
-
February 24, 2023
Akorn Files For Ch. 7 Liquidation With Over $100M Debt
Remnants of recently bankrupt specialty pharmaceutical venture Akorn Pharmaceuticals and two affiliates have crossed over from Chapter 11 to Chapter 7 liquidation in Delaware, with a worker complaint in tow alleging violations of federal plant closing and layoff regulations.